Radiofrequency Ablation of Hepatocellular Carcinoma

Surgical Oncology Clinics of North America

Volumn 20, Issue 2, 2011, Pages 281-299

  Livraghi, Tito ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Hepatocellular carcinoma; Percutaneous ablation procedure; Radiofrequency ablation

Indexed keywords

ACETIC ACID; ALCOHOL;

ADVERSE OUTCOME; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; ECHOGRAPHY; GOLD STANDARD; HUMAN; INTERMETHOD COMPARISON; LIVER CELL CARCINOMA; LIVER RESECTION; MINIMALLY INVASIVE PROCEDURE; OVERALL SURVIVAL; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; RADIATION EQUIPMENT; RADIOFREQUENCY ABLATION; REVIEW; THERAPY EFFECT; TREATMENT INDICATION; TREATMENT PLANNING; TUMOR VOLUME;

CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; HUMANS; LIVER NEOPLASMS;

EID: 79952154986     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2010.11.010     Document Type: Review

References (72)

1. Livraghi T., Festi D., Monti F., et al. US-guided percutaneous alcohol injection of small hepatic and abdominal tumors. Radiology 1986, 161:309-312.
2. Masters A., Steger A.C., Lees W.R. Interstitial laser hyperthermia: a new approach for treating liver metastases. Br J Cancer 1992, 66:518-522.
3. Rossi S., Fornari F., Buscarini L., et al. Percutaneous ultrasound guided radiofrequency electrocautery for the treatment of small hepatocellular carcinoma. J Intervent Radiol 1993, 8:97-103.
4. Ohnishi K., Ohyama M., Ito S., et al. Ultrasound guided intratumor injection of acetic acid for the treatment of small hepatocellular carcinoma. Radiology 1994, 193:747-752.
5. Murakami R., Yoshimatsu S., Yamashita, et al. Treatment of hepatocellular carcinoma: value of percutaneous microwaves coagulation. Am J Roentgenol 1995, 164:1159-1164.
6. Livraghi T., Vettori C., Torzilli G., et al. Percutaneous ethanol injection of hepatic tumors: single session therapy under general anesthesia. Am J Roentgenol 1993, 160:1065-1069.
7. Gazelle G.S., Goldberg S.N., Solbiati L., et al. Tumor ablation with radiofrequency energy. Radiology 2000, 217:633-646.
8. McGahan P.J., Dodd D.G. Radiofrequency ablation of the liver: current status. Am J Roentgenol 2001, 176:3-16.
9. Goldberg S.N., Gazelle G.S., Solbiati L., et al. Radiofrequency tissue ablation: increased lesion diameter with a perfusion electrode. Acad Radiol 1996, 3:636-644.
10. Goldberg S.N., Solbiati L., Hahn P.F., et al. Large volume tissue ablation with radiofrequency by using a clustered, internally cooled electrode technique: laboratory and clinical experience in liver metastases. Radiology 1998, 209:371-379.
11. Shibata T., Shibata T., Maetani Y., et al. Radiofrequency ablation for small hepatocellular carcinoma: prospective comparison of internally cooled electrode and expandable electrode. Radiology 2006, 238:346-353.
12. Lin S.M., Lin C.C., Chen W.T., et al. Radiofrequency ablation for hepatocellular carcinoma: a prospective comparison of four radiofrequency devices. J Vasc Interv Radiol 2007, 18:1118-1125.
13. Rhim H., Lim H.K., Kim Y.S., et al. Radiofrequency ablation of hepatic tumors: lessons learned from 3000 procedures. J Gastroenterol Hepatol 2008, 23:1492-1500.
14. Livraghi T., Meloni F., Morabito A., et al. Multimodal image-guided tailored therapy of early and intermediate hepatocellular carcinoma: long-term survival in the experience of a single radiologic referral center. Liver Transpl 2004, 10:S98-S106.
15. Kim S.K., Rhim H., Kim Y.S., et al. Radiofrequency thermal ablation of hepatic tumor: pitfalls and challenges. Abdom Imaging 2005, 30:727-733.
16. Koda M., Ueki M., Maeda Y., et al. Percutaneous sonographically guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma located under the diaphragm. AJR Am J Roentgenol 2004, 183:583-588.
17. Rhim H., Lim H.K., Kim Y.S., et al. Percutaneous radiofrequency ablation with artificial ascites for hepatocellular carcinoma in the hepatic dome: initial experience. AJR Am J Roentgenol 2008, 190:91-98.
18. Chen M.H., Wei Y., Yan K., et al. Treatment strategy to optimize radiofrequency ablation for liver malignancy. J Vasc Interv Radiol 2006, 17:671-683.
19. Hinshaw J.L., Laeseke P.F., Winter T.C., et al. Radiofrequency thermal ablation of peripheral liver tumors: intraperitoneal 5% dextrose in water decrease postprocedural pain. AJR Am J Roentgenol 2006, 186:S306-S310.
20. Lu D.S., Raman S.S., Vodopich D.J., et al. Effect of vessel size on creation of hepatic radiofrequency lesions in pigs: assessment of the "heat sink" effect. AJR Am J Roentgenol 2002, 1787:47-51.
21. Meloni F., Goldberg S.N., Livraghi T., et al. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT. AJR Am J Roentgenol 2001, 177:375-380.
22. Elias D., DeBaere T., Muttillo I., et al. Intraoperative use of radiofrequency treatment allows an increase in the rate of curative liver resection. J Surg Oncol 1998, 67:190-191.
23. Montorsi M., Santambrogio R., Bianchi P., et al. Radiofrequency interstitial thermal ablation of hepatocellular carcinoma in liver cirrhosis. Role of the laparoscopic approach. Surg Endosc 2001, 15:141-145.
24. Mulier S., Ni Y., Jamart J., et al. Local recurrence after hepatic radiofrequency coagulation. Multivariate meta-analysis and review of contributing factors. Ann Surg 2005, 242:158-171.
25. Meloni F., Livraghi T., Filice C., et al. Radiofrequency ablation of liver tumors: the role of microbubble ultrasound contrast agents. Ultrasound Q 2006, 22:41-47.
26. Livraghi T., Solbiati L., Meloni F., et al. Treatment of focal liver tumors with radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003, 226:441-451.
27. de Baere T., Risse O., Kuoch V., et al. Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR Am J Roentgenol 2003, 181:695-700.
28. Curley S.A., Marra P., Beaty K., et al. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg 2004, 239:450-458.
29. Kasugai H., Osaki Y., Oka H., et al. Severe complications of radiofrequency ablation therapy for hepatocellular carcinoma: an analysis of 3,891 ablations in 2,614 patients. Oncology 2007, 1:S72-S75.
30. Mulier S., Mulier P., Ni Y., et al. Complications of radiofrequency coagulation of liver tumours. Br J Surg 2002, 89:1206-1222.
31. Llovet J.M., Vilana R., Brù C., et al. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology 2001, 33:1124-1129.
32. Poon R.T., Ng K.K., Lam C.M., et al. Radiofrequency ablation for subcapsular hepatocellular carcinoma. Ann Surg Oncol 2004, 11:281-289.
33. Livraghi T., Lazzaroni S., Meloni F., et al. Risk of tumour seeding after percutaneous radiofrequency ablation for hepatocellular carcinoma. Br J Surg 2005, 92:856-858.
34. Poon R.T., Ng K.K., Lam C.M., et al. Learning curve for radiofrequency ablation of liver tumors: prospective analysis of initial 100 patients in a tertiary institution. Ann Surg 2004, 239:441-449.
35. Bruix J., Sherman M. Management of hepatocellular carcinoma. Hepatology 2005, 42:1208-1236.
36. Kojiro M., Nakashima O. Histopathologic evaluation of hepatocellular carcinoma with special reference to small early stage tumors. Semin Liver Dis 1999, 19:287-296.
37. Kojiro M. Focus on dysplastic nodules and early hepatocellular carcinoma: an Eastern point of view. Liver Transpl 2004, 10(Suppl):3A-8A.
38. Okusaka T., Okada S., Ueno H., et al. Satellite lesions in patients with small hepatocellular carcinoma with reference to clinicopathologic features. Cancer 2002, 95:1931-1937.
39. Nakashima Y., Nakashima O., Tanaka M., et al. Portal vein invasion and intrahepatic micrometastasis in small hepatocellular carcinoma by gross type. Hepatol Res 2003, 26:142-147.
40. Maeda T., Takenaka K., Taguchi K., et al. Small hepatocellular carcinoma with minute satellite nodules. Hepatogastroenterology 2000, 47:1063-1066.
41. Sasaki Y., Imaoka S., Ishiguro S., et al. Clinical features of small hepatocellular carcinomas as assessed by histologic grades. Surgery 1996, 119:252-260.
42. Kanai T., Hirohashi S., Upton M.P., et al. Pathology of small hepatocellular carcinoma. Cancer 1987, 60:810-819.
43. Huang G.T., Lee P.H., Tsang Y.M., et al. Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study. Ann Surg 2005, 242:36-42.
44. Chen M.S., Li J.Q., Zheng Y., et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006, 243:321-328.
45. Lu M.D., Kuang M., Liang L.J., et al. Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial. Zhonghua Yi Xue Za Zhi 2006, 86:801-805.
46. Gournay J., Tchuenbou J., Richou C., et al. Percutaneous ethanol injection vs. resection in patients with small single hepatocellular carcinoma: a retrospective case-control study with cost analysis. Aliment Pharmacol Ther 2002, 16:1526-1538.
47. Daniele B., de Sio I., Izzo F., et al. Hepatic resection and percutaneous ethanol injection as treatments of small hepatocellular carcinoma: a CLIP retrospective case-control study. J Clin Gastroenterol 2003, 36:63-67.
48. Livraghi T., Meloni F., Di Stasi M., et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice?. Hepatology 2008, 47:82-89.
49. Livraghi T., Goldberg S.N., Lazzaroni S., et al. Small hepatocellular carcinoma: treatment with radiofrequency ablation versus ethanol injection. Radiology 1999, 210:655-661.
50. Lencioni R., Allgaier H.P., Cioni D., et al. Small hepatocellular carcinoma: randomized comparison of radiofrequency thermal ablation versus percutaneous ethanol injection. Radiology 2003, 228:235-240.
51. Lin S.M., Lin C.J., Lin C.C., et al. Randomized controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 2005, 54:1151-1156.
52. Shiina S., Teratani T., Obi S., et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005, 129:122-130.
53. Brunello F., Veltri A., Carucci P., et al. Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: a randomized controlled study. Scand J Gastroenterol 2008, 43:727-735.
54. Bouza C., Lopez-Cuadrado T., Alcazar R., et al. Meta-analysis of percutaneous radiofrequency ablation versus ethanol injection in hepatocellular carcinoma. BMC Gastroenterol 2009, 9:31-40.
55. Orlando A., Leandro G., Olivo M., et al. Radiofrequency thermal ablation vs percutaneous ethanol injection for small hepatocellular carcinoma: meta-analysis of randomized controlled trials. Am J Gastroenterol 2009, 104:514-524.
56. Cho Y.K., Kim J.K., Kim W.T., et al. Hepatic resection versus radiofrequency ablation for very early stage hepatocellular carcinoma: a Markov model analysis. Hepatology 2010, 51:1-7.
57. Livraghi T., Bolondi L., Buscarini L., et al. No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. J Hepatol 1995, 22:522-526.
58. Ryu M., Shimamura Y., Kinoshita T., et al. Therapeutic results of resection, transcatheter arterial embolization and percutaneous ethanol injection in 3225 patients with hepatocellular carcinoma: a retrospective multicenter study. Jpn J Clin Oncol 1997, 27:251-257.
59. Cho C.M., Tak W.Y., Kweon Y.O., et al. Korean J Hepatol 2005, 11:59-71. [in Korean].
60. Hong S.N., Lee S.Y., Choi M.S., et al. Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function. J Clin Gastroenterol 2005, 39:247-252.
61. Ogihara M., Wong L.L., Machi J. Radiofrequency ablation versus surgical resection for single nodule hepatocellular carcinoma: long-term results. HPB (Oxford) 2005, 7:214-221.
62. Wakai T., Shirai Y., Suda T., et al. Long-term outcomes of hepatectomy vs percutaneous ablation for treatment of hepatocellular carcinoma. World J Gastroenterol 2006, 12:546-552.
63. Takahashi S., Kudo M., Chung H., et al. Outcomes of nontransplant potentially curative therapy for early stage hepatocellular carcinoma in Child-Pugh stage A cirrhosis is comparable with liver transplantation. Dig Dis 2007, 25:303-309.
64. Hasegawa K., Makuuchi M., Takayama T., et al. Surgical resection vs percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. J Hepatol 2008, 49:589-594.
65. Nanashima A., Masuda J., Miuma S., et al. Selection of treatment modality for hepatocellular carcinoma according to the modified Japan Integrated Staging score. World J Gastroenterol 2008, 14:58-63.
66. Abu-Hilal M., Primrose J.N., Casaril A., et al. Surgical resection versus radiofrequency ablation in the treatment of small unifocal hepatocellular carcinoma. J Gastrointest Surg 2008, 12:1521-1526.
67. Ueno S., Sakoda M., Kubo F., et al. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria. J Hepatobiliary Pancreat Surg 2009, 16:359-366.
68. Llovet J.M., Fuster J., Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma. Hepatology 1999, 30:1434-1440.
69. Yao F.Y., Kerlan R.K., Hirose R., et al. Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology 2008, 48:819-827.
70. Maluf D., Fisher R.A., Maroney T., et al. Non-resective ablation and liver transplantation in patients with cirrhosis and hepatocellular carcinoma: safety and efficacy. Am J Transplant 2003, 3:312-317.
71. Lao O.B., Weissman J., Perkins J.D. Pre-transplant therapy for hepatocellular carcinoma is associated with a lower recurrence after liver transplantation. Clin Transplant 2009, 23:874-881.
72. Cabibbo, Latteri F., Antonucci, et al. Multimodal approaches to the treatment of hepatocellular carcinoma. Nat Clin Pract Gastroenterol Hepatol 2009, 6:159-169.